• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tevogen Bio Holdings Inc. - Common Stock (NQ:TVGN)

10.48 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tevogen Bio Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Letter to Shareholders from CEO Dr. Ryan Saadi
May 18, 2026
From Tevogen Bio Inc
Via GlobeNewswire
What's going on in today's session ↗
May 14, 2026
Via Chartmill
News headline image
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
May 12, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
April 27, 2026
From Tevogen Bio Inc
Via GlobeNewswire
What's going on in today's pre-market session ↗
April 24, 2026
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
April 21, 2026
Via Chartmill
News headline image
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
March 26, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
March 25, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
March 18, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
March 13, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
March 13, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
March 11, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
March 09, 2026
U.S. stock futures lower, with Dow futures down over 1%. BETA Technologies (NYSE: BETA) fell in pre-market trading after reporting fourth-quarter results. Other stocks declining in pre-market trading... 
Via Benzinga
Topics Stocks
News headline image
Tevogen Names Leadership Team to Execute Diversified Growth Strategy
March 09, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen CEO Says ‘Actively Evaluating’ Potential Acquisitions ↗
March 06, 2026
The announcement comes on the heels of the company announcing that it has entered into a letter of intent to evaluate a deal with another pharmaceutical company called Apozel Pharmaceuticals. 
Via Stocktwits
News headline image
Letter to Shareholders from CEO Dr. Ryan Saadi
March 06, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Shares Take Further Beating On Gauging Deal With Apozel Pharmaceuticals ↗
March 05, 2026
If the deal goes through, it could provide Tevogen with an established generics platform, the company said. 
Via Stocktwits
News headline image
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical
March 05, 2026
From Tevogen Bio Inc
Via GlobeNewswire
Discover the top movers in Wednesday's pre-market session. ↗
March 04, 2026
Via Chartmill
News headline image
Tevogen Announces Reverse Stock Split
March 04, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
February 27, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
February 26, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
February 26, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders
January 30, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue
January 29, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
FDA Reversal Sends Atara Biotherapeutics into Tailspin: Stock Plummets 67% on Second CRL for Tabelecleucel
January 14, 2026
In a stunning blow to the burgeoning field of allogeneic cell therapy, Atara Biotherapeutics (Nasdaq: ATRA) saw its market valuation evaporate this week following a second Complete Response Letter... 
Via MarketMinute
Topics Bankruptcy
News headline image
Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025
January 12, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen CEO Donates Shares to Support Education for Underprivileged Children
December 22, 2025
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen CEO Donates Personal Shares to Support Local Fire Department
December 19, 2025
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen CEO Supports Local Law Enforcement with Personal Contribution of 230,000 Company’s Shares of Common Stock
December 11, 2025
From Tevogen Bio Inc
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap